Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Stem Cell Engineering Gets a Boost with Discovery of Fine-Tuning Knob

Page View:

    Researchers at the University of California San Diego say they have discovered a protein that regulates the switch of embryonic stem cells from the least developed naïve state to the more developed primed state. This discovery sheds light on stem cell development at a molecular level, according to the investigators who published their study (“SMARCAD1 Contributes to the Regulation of Naive Pluripotency by Interacting with Histone Citrullination”) online in Cell Reports.

    “This discovery provides a fine-tuning knob for the stem cell engineering toolkit,” said Sheng Zhong, Ph.D., a bioengineering professor at the UC San Diego Jacobs School of Engineering and the study’s senior author. “A number of previously identified regulatory proteins can be considered as rough-tuning knobs that result in greater changes in cellular behavior. We need both tools to precisely set stem cells into the desired cellular state so that they can carry out the functions that we desire.”

    The scientists discovered that the protein, called SMARCAD1, interacts with a specific type of histone modification, called histone citrullination (H3R26Cit), to prevent the spontaneous switch from the naïve to the primed pluripotent state. By suppressing SMARCAD1 from interacting with H3R26Cit, researchers were able to induce this switch. They also found that the stem cells with suppressed SMARCAD1 expression remained pluripotent. “This finding offers an approach to fine-tune the stem cells between two cellular states corresponding to two early developmental stages,” said Jia Lu, a bioinformatics Ph.D. student in Zhong’s research group who co-authored this work.

    Zhong and his team first used protein arrays composed of hundreds of histone peptides harboring distinct post-transcriptional modifications and found that SMARCAD1 specifically interacts with the H3R26Cit modification. They then used a technology called ChIP-seq, or chromatin immunoprecipitation sequencing, to assay genome-wide distributions of SMARCAD1 binding as well different kinds of histone modifications. They found that SMARCAD1 specifically binds to H3R26Cit-modified histones in the entire genome.

    The team also conducted experiments in which they suppressed the expression of SMARCAD1, and a separate set of experiments in which they suppressed a more general form of H3R26Cit called H3Cit. In both experiments, they observed cellular changes consistent with the switch from the naïve to the primed stem cell state, providing more evidence of SMARCAD1’s regulatory role in stem cell development.

    Moving forward, the team is investigating whether SMARCAD1 also plays a role in regulating the behavior or cancer cells.

Relevant newsRelevant news